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Plasma homocysteine levels in patients with liver cirrhosis
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Abstract
Background/Aim. Homocysteine (2-amino-4-mercapto-
butyric acid) is an amino acid that may be found in small
quantities in all cells, and is quantitatively the major
methionine metabolite. The most prevalent form is pro-
tein-bound homocysteine (about 80%), mostly to albu-
mins. If catabolism of homocysteine is impaired either
due to enzyme defect or deficiency of required intracellu-
lar cofactors, homocysteine accumulates in cells and
reaches the circulation. The aim of our study was to de-
termine homocysteine values and factors affecting homo-
cysteine metabolism in patients with liver cirrhosis.
Methods.  The prospective study included 35 patients
with liver cirrhosis and 30 age and sex matched healthy
controls. All the examinations were based on: medical
history, physical examination, laboratory tests including
serum homocysteine levels and liver biopsy. The degree
of liver failure was assessed according to the Child-Pugh
classification.  Results.  The  mean plasma homocysteine
levels were much higher in the patients with liver cirrhosis
than in the healthy controls (t-test, p < 0.001). There was
no significant difference between the plasma homocys-
teine concentration and etiology of liver cirrhosis
(ANOVA, p > 0.05). Correlation analysis showed a posi-
tive correlation between the homocysteine and creatinine
concentrations and between the serum albumin and ho-
mocysteine values, (Pearson's correlation, p < 0.01,  and
p < 0.05 respectively). Conclusion. In liver cirrhosis, the
genesis of homocysteinemia is multifactorial, influenced
significantly by impaired catabolic liver function, renal
failure and hypoalbuminemia.
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Apstrakt
Uvod/Cilj.  Homocistein (2-amino-4-merkapto-buterna
kiselina) je aminokiselina koja se nalazi u malim koliÿinama
u svim ýelijama, i predstavlja glavni metabolit metionina.
Homocistein se u serumu nalazi najÿešýe vezan za albumin
(oko 80%). U stanjima u kojima dolazi do poremeýaja ka-
tabolizma homocisteina, zbog enzimskog defekta ili nedo-
statka intracelularnih kofaktora neophodnih za njegov
metabolizam, homocistein se skladišti u ýelijama i dospeva
u cirkulaciju u slobodnom obliku. Cilj ove studije bio je
utvrĀivanje nivoa homocisteina kod bolesnika sa cirozom
jetre i faktora koji mogu da utiÿu na njegov metabolizam.
Metode. Ovom prospektivnom studijom bilo je obuhva-
ýeno 35 bolesnika sa cirozom jetre i 30 zdravih osoba koje
su ÿinile kontrolnu grupu. Grupe zdravih ispitanika i bole-
snika bile su podudarne prema polu i uzrastu. Kod svih is-
pitanika ispitivanje je obuhvatilo anamnestiÿke podatke, fi-
zikalni pregled, laboratorijske analize ukljuÿujuýi i nivo
homocisteina u serumu, kao i biopsiju jetre u grupi boles-
nika sa cirozom jetre. Stepen ošteýenja jetre procenjivan je
primenom Child-Plugh klasifikacije. Rezultati.  Bolesnici
sa cirozom jetre imali su u proseku više vrednosti homoci-
steina nego zdravi ispitanici (t-test,  p < 0,001).  Etiološki
faktori za nastanak ciroze jetre (alkohol, virusi, autoimun-
ski, kriptogena ciroza) nisu uticali na nivo homocisteina u
serumu (ANOVA, p > 0,05). TakoĀe, utvrĀeno je postoja-
nje pozitivne korelacije izmeĀu nivoa homocisteina i krea-
tinina, odnoso albumina u krvi kod bolesnika sa cirozom
jetre (Pearson-ov koeficijent korelacije, p < 0,01 i p < 0,05
respektivno). Zakljuÿak. Bolesnici sa cirozom jetre imaju
više vrednosti homocisteina u krvi, što je posledica brojnih
faktora kao što su ošteýena funkcija jetre, bubrežna insufi-
cijencija i hipoalbuminemija.
Kljuÿne reÿi:
homocistein; jetra, ciroza; hipoalbuminemija;
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Introduction
Homocysteine (2-amino-4-mecarpto-butinic acid) is an
amino acid that may be found in small quantities in all cells,
and it is quantitatively the major methionine metabolite.
Moreover, homocysteine can be found either free in a body
or in the form of disulfide and proteins. In relation to a total
homocysteine quantity, free or reduced one accounts for only
1%–2%. However, the most prevalent form is protein-bound
homocysteine (about 80%), mostly to albumins 
1.
It is well-known, that a high level of blood serum ho-
mocysteine is a powerful risk factor for cardiovascular dis-
ease 
2. On the other hand, elevated levels of homocysteine
have been linked to increased fractures in elderly persons 
3.
The liver has an important role in metabolism of homo-
cystine. It is condensed with serine and upon separation of
molecule of water and cystathionine-ȕ-synthetase (vitamin
B6 dependent enzyme) it yields cystathionine. Cystathionine,
breaks down to homoserine and cysteine, by the action of
cystathionase (vitamin B6 dependent enzyme). Homoserine
is transformed into D-ketobutyric acid under the action of
homoserine desaminase, when ammonium hydroxide and
hydrogen sulfide are being separated from it. Homocysteine
may in one part, oxidize to homocystine. Methionine may be
resynthesized from homocysteine and methyl-tetrahydrofolic
acid 
4.
If catabolism of homocysteine is impaired either due to
enzyme defect or deficiency of required intracellular cofac-
tors, homocysteine accumulates in cells and reaches the cir-
culation.
The aim of our study was to determine homocysteine
values and factors affecting the homocysteine metabolism in
patients with liver cirrhosis.
Methods
In the period from August 2008 to April 2009, the pro-
spective study included 35 patients with liver cirrhosis and
30 age and sex matched healthy controls examined at the
Clinic of Gastroenterology and Hepatology, Clinical Center
of Serbia, Belgrade. Written informed consent was obtained
from each subject.
Inclusion criterion was the patients’ diagnosis of liver
cirrhosis as an underlying disease. All the examinations were
based on: medical history, physical examination, laboratory
tests and liver biopsy. Laboratory tests included: liver func-
tional tests as well as specific (etiological) tests. Puncture
liver biopsy was performed in 7 (20%) patients, using the 1.4
mm Menghini needle. The degree of liver failure was assessed
according to Child-Pugh classification.
A day after an overnight fast, fasting blood samples
were drawn to determine biochemical indices and homocys-
teine determination were collected in additive-free Vacutainers
(BD), centrifuged at 3,500 rpm (| 2,000 g) 10 minutes, using the
“Heraeus Digifuga GL” centrifuge. After separation, serum was
stored at -20
oC until measurement. Blood was drawn between 8
and 9 a.m. Homocysteine was measured by commercial test kits
by means of Immulite, (Siemens, USA) and expressed in Pmol/L.
The results were expressed as mean ± SD or as stated.
Distribution data were compared by 
2-test. The differences
between the groups were analysed using a paired Student's t-
test and correlation coefficients (Spearman 
1, correlation and
Person’s correlation test). All statistical analyses were per-
formed with the SPSS 10.0 for Windows package (SPSS
Inc., Chicago, IL). The values
 at the p = 0.05 level were con-
sidered statisticaly significant.
Results
The most common cause of liver cirrhosis was alcohol
– 21 (60%) patients. The incidence of posthepatitis liver cir-
rhosis was lower – 7 (20%) of the patients, autoimmune liver
diseases were quite rare – 4 (11.4%) of the patients, while
etiology was unknown in 3 (8.6 %) of the cases.
The patients were classified into 3 classes according to
generally accepted Child's system. Child-Pugh class A in-
cluded 19 (54.2%), class B 8 (22.9%), and class C 8 (22.9%)
of the patients.
The mean plasma homocysteine levels were much
higher in the patients with the cirrhosis than in healthy con-
trols. A statistically significant difference was found between
homocysteine plasma values in patients with cirrhosis and
healthy subjects (14.85 ± 5.40 versus 9.17 ± 1.99 ȝmol/L, t-
test, p < 0.001).
On the other hand, there was no significant difference
between the plasma homocysteine concentration and etiology
of the cirrhosis (ANOVA, p > 0.05).
In relation to creatinine concentration, the patients were
divided into two subgroups, i.e. with normal (< 120 ȝmol/L)
and higher creatinine levels (> 120 ȝmol/L). The normal cre-
atinine values were reported in 28 (80%) of the patients and
higher levels were recorded in 7 (20%) of the cases.
Correlation analysis showed a positive correlation be-
tween homocysteine and creatinine concentrations (Pear-
son’s test, r  = 0.4622; t = 2.994,  p < 0.01).  In  addition,  a
positive correlation between the serum albumin and homo-
cysteine values was also established (Pearson’s correlation,
p < 0.05).
Discussion
Patients with cirrhosis develop a hyperdynamic state of
circulation, with high cardiac output, increased blood vol-
ume, reduced systemic vascular resistance, and they are
prone to arterial hypotension. Increased hepatic and collat-
eral resistances as well as portal blood flow maintain portal
hypertension 
5, 6.
It is considered that bacterial lipopolysaccharide endo-
toxins cause multiple-hour release of nitric oxide (NO) from
vascular endothelium, what leads to peripheral vasodilata-
tion, hypotension and tachycardia. In vitro effect of endo-
toxin and cytokine on NO synthesis induction has been
proved in endothelium and smooth muscles with progressive
vascular relaxation and poorer response to vasoconstrictors 
7.
High circulating endotoxin concentrations were found
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signs of infection. The endotoxins in cirrhosis are supposed
to induce, directly or indirectly, the increase of NO release
and synthesis, which causes the methionine-synthase inacti-
vation, giving rise to accumulation of homocysteine in cells
and extracellular space 
8.
Homocysteine and related biogenic thiols produce
chemically and physiologically specific products in reactions
with nitric oxides: nitrogen dioxide, dinitrogen trioxide and
dinitrogen tetroxide. A tendency towards interaction with
metal nitrosyl complexes is also manifested. In both cases,
reaction products are S-nitrosothiol or thionitrites. These
substances strongly activate the enzyme guanylate cyclase
and are an important intermediary agent in metabolism of the
endothelium-relaxing factor (EDRF) 
9.
Elevated homocysteine levels in cells and extracellular
space, by inducing the synthesis of vasoactive EDRF, are in-
volved in the pathogenesis of hyperdynamic circulation.
The study by Woitas et al. 
10 found significantly higher
homocysteine concentrations in cirrhotic patients in relation
to the controls (p = 0.0002), and a non-significant correlation
between homocysteine concentration and degree of liver in-
sufficiency according to the Child-Pugh classification
(p = 0.1).
Ferre et al. 
11 analyzed 76 patients with cirrhosis. Alco-
holic cirrhosis was diagnosed in 48 (63%) of the patients and
non-alcoholic in 28 (37%) of the cases. They verified higher
homocysteine concentrations in cirrhotic patients in relation
to the healthy controls which depended upon the extent of
liver impairment. No difference in homocysteine concentra-
tions between alcoholic and nonalcoholic cirrhosis was
found.
Our studies are compatible with those of Woitas et al. 
10
and Ferre et al. 
11. In our study as in the study by Woitas et
al. 
10 there was no correlation between homocysteine con-
centrations and liver insufficiency according to the Child-
Pugh classification (p > 0.05). It differs from the study by
Ferre et al. 
11 which noted that higher homocysteine concen-
trations correlated with more severe degree of liver insuffi-
ciency.
The kidneys are considered to have a major role in ho-
mocysteine metabolism and are involved in about 70%-
elimination of homocysteine from plasma, by glomerular fil-
tration and metabolism in tubular cells, breakdown through
transsulfuration or remethylation into methionine. Some arti-
cles report that homocystinemia directly correlates with se-
rum creatinine and glomerular filtration 
12.
A significance of tubular metabolism of homocysteine
has been corroborated by clinical studies. Renal posttrans-
plantation levels of homocysteine are much higher in com-
parison to patients with end-stage renal failure who had not
undergone transplantation. During transplantation, a kidney
is subjected to ischemic injury of tubular cells, which may be
additionally damaged by immunological reactions and im-
munosuppressive drugs. Lower homocysteine metabolism in
tubules causes higher homocysteine values 
13.
Our study found a positive correlation between homo-
cysteine and creatinine levels (p < 0.01). Given that in our
study only 7 (20%) of the patients had impaired renal func-
tion, evaluated on the basis of higher creatinine values, ho-
mocystinemia in cirrhosis could not be accounted for disor-
dered glomerular filtration and tubular metabolism only.
Suliman et al. 
14 indicated that blood homocysteine
level was lower in patients with end-stage renal failure with
cardiovascular diseases and they associated such paradox
with hypoalbuminemia.
It is well-known that plasma homocysteine may be
found in several forms. The majority, about 70%, is bound to
plasma proteins, ie. to albumin, mostly via cysteine, while
the remaining free homocysteine is, due to high reactivity of
the thiol group, susceptible to autooxidation and formation of
disulfide bonds; the rest is composed of free, reduced form
of homocysteine (only 1% of total plasma homocys-
teine) 
14, 15. Our study found a positive correlation between
albumin and homocysteine, what is in compliance with the
past results.
On the other hand, it is well known that vitamin B6 de-
ficiency is usually the result of malabsorption syndrome,
uremia, cancer, cirrhosis, alcoholism, old age, and preg-
nancy 
16. Moreover, it is showed that plasma levels of pyri-
doxal-5'-phosphate (PLP) in cirrhotic patients were signifi-
cantly lower than in healthy control subjects 
17.
Nutrition regime significantly interferes with the level
of homocysteine that may vary in relation to methionine in-
take by food. Animal food is richer in methionine than plant
one. Meat and fish contain 2.7 g/100 g, eggs 3.2g/100 g, cow
milk 2.9 g/100 mL of methionine versus fruit and vegetables
containing only 0.9–1.2 g/100g 
15, 18. Although the nutritive
status was not the subject of analysis in our study, it is well-
known that cirrhotic patients have poor appetite and reduced
intake of proteins in relation to healthy subjects 
19.
Conclusion
In liver cirrhosis, the genesis of homocystinemia is
multifactorial, influenced significantly by impaired catabolic
liver function, renal failure and hypoalbuminemia.
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